ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
0,00%
Bitcoin
62.739,43
-0,49%
Brent Oil
84,155
0,24%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Equillium Inc (EQ)

  7. Equillium Inc (EQ) Notícias

EQ

Equillium (EQ)

Equillium Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EQ
DataHoraFonteTítuloCódigoCompanhia
09/05/202417:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQEquillium Inc
09/05/202417:01Business WireEquillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical HighlightsNASDAQ:EQEquillium Inc
07/05/202409:00Business WireEquillium Announces Poster Presentation at the Annual Meeting of The American Association of ImmunologistsNASDAQ:EQEquillium Inc
03/04/202409:00Business WireEquillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EQEquillium Inc
01/04/202409:00Business WireEquillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus NephritisNASDAQ:EQEquillium Inc
25/03/202417:01Business WireEquillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical HighlightsNASDAQ:EQEquillium Inc
22/03/202409:00Business WireEquillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational ConferenceNASDAQ:EQEquillium Inc
08/03/202419:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EQEquillium Inc
08/03/202418:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
23/02/202419:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EQEquillium Inc
03/01/202420:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
21/12/202310:00Business WireEquillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac DiseaseNASDAQ:EQEquillium Inc
20/11/202313:23PR Newswire (US)EQ Bank Card launches in Québec as Carte Banque EQNASDAQ:EQEquillium Inc
13/11/202311:00Business WireEquillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of RheumatologyNASDAQ:EQEquillium Inc
08/11/202318:01Business WireEquillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:EQEquillium Inc
06/11/202310:00Business WireEquillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of NephrologyNASDAQ:EQEquillium Inc
19/10/202309:00Business WireEquillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of RheumatologyNASDAQ:EQEquillium Inc
16/10/202309:00Business WireEquillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics SymposiumNASDAQ:EQEquillium Inc
03/10/202309:00Business WireEquillium to Host Analyst & Investor DayNASDAQ:EQEquillium Inc
02/10/202309:00Business WireEquillium to Present at the JonesTrading 2023 Healthcare SummitNASDAQ:EQEquillium Inc
20/09/202309:00Business WireEquillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event ConferencesNASDAQ:EQEquillium Inc
30/08/202309:00Business WireEquillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor ConferenceNASDAQ:EQEquillium Inc
09/08/202317:01Business WireEquillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:EQEquillium Inc
02/08/202317:00Business WireEquillium Announces $7.5 Million Share Repurchase ProgramNASDAQ:EQEquillium Inc
01/06/202309:00Business WireEquillium to Present at the Jefferies Global Healthcare & LD Micro Invitational ConferencesNASDAQ:EQEquillium Inc
25/05/202317:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EQEquillium Inc
23/05/202319:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EQEquillium Inc
11/05/202317:01Business WireEquillium Reports First Quarter 2023 Financial Results and Provides Clinical UpdatesNASDAQ:EQEquillium Inc
24/04/202309:00Business WireEquillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow TransplantationNASDAQ:EQEquillium Inc
13/04/202317:08Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:EQEquillium Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:EQ

Seu Histórico Recente

BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
TELB4
TELEBRAS PN
BOV
VVEO3
CM Hospitalar ON
BOV
IBOV
Índice Bovespa
BOV
IFCM3
Infracommerce Caxaas ON
BOV
CASH3
Meliuz S.A ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados